Investor Relations


Subscribe to our mailing list!

Investor FAQs


What does Adherium do?

Adherium is a provider of digital health solutions that address sub-optimal medication use and improve health outcomes in chronic disease. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of "smart" device sensors for respiratory medications. The first Smartinhaler™ was developed for use in clinical trials in 2003, and since then the company has expanded its technology platform and Smartinhaler™ productrange. Adherium operates globally from bases in the USA, Europe, and Australasia.

Where is Adherium’s corporate headquarters?

Suite 150
1800 Gateway Dr
San Mateo, California 94404 USA

On what stock exchange is Adherium traded and what is the ticker symbol?

Adherium is listed on the ASX market, the primary registered stock exchange in Australia operated by ASX Limited. The ticker symbol is ADR. For most stock-tracking software, including mobile phone apps, use the symbol ADR.AX

How can I invest in Adherium?

Bell Potter
1300-0-BELLS

When does Adherium’s fiscal year end?

June 30

When is Adherium’s Annual Stockholders Meeting?

November 29, 2017
Click here for more information

Who is the Company’s outside legal counsel?

K&L Gates LLC 

Who is Adherium’s independent auditor?

PricewaterhouseCoopers LLP

Who are the members of Adherium’s Board of Directors?

Click here to view the members of Adherium's board.

Who are the members of Adherium’s management team?

Click here to view the members of Adherium's management team.

How do I contact Investor Relations with a question or request?

Link to Contact Us or investors@adherium.com

Who do I contact with questions about Adherium’s shares?

Bell Potter
1300-0-BELLS